1
Clinical Trials associated with KJ-101(Shanghai Bao Phaemaceuticals)A Multicentre, Randomised, Double-blind, Dose-exploratory, Controlled Drug and Placebo-controlled Phase II Clinical Trial Evaluating the Safety, Efficacy, Pharmacokinetic Profile, and Immunogenicity of KJ101 for Wound Debridement in Deep II Degree Burns
This multicentre, randomised, double-blind, dose-finding, active- and placebo-controlled Phase II clinical trial will evaluate the safety, efficacy, pharmacokinetic profile, and immunogenicity of KJ101 for the debridement of deep second-degree burns. The trial will provide supporting evidence for subsequent Phase III trials.
100 Clinical Results associated with KJ-101(Shanghai Bao Phaemaceuticals)
100 Translational Medicine associated with KJ-101(Shanghai Bao Phaemaceuticals)
100 Patents (Medical) associated with KJ-101(Shanghai Bao Phaemaceuticals)
100 Deals associated with KJ-101(Shanghai Bao Phaemaceuticals)